Core Insights - ThreeD Capital Inc. congratulates AI/ML Innovations Inc. on signing a Letter of Intent with Circular Health Limited to integrate and license Neural Cloud's ECG signal-processing platform, MaxYield™ [1][2] - The integration phase will involve deploying MaxYield through a cloud-based API, with a target for commercial launch by September 2025 [2] - ThreeD Capital holds 20,899,200 common shares and 27,000,000 common share purchase warrants of AIML, indicating a significant investment in the company [2] Company Overview - ThreeD Capital is a Canadian-based venture capital firm focused on opportunistic investments in junior resources and disruptive technologies sectors [4] - The investment strategy includes investing in multiple private and public companies globally, particularly in early-stage promising companies [4] - The firm aims to be a lead investor and provide advisory services and access to its ecosystem for investees [4]

Leadership Transition - Matthew Hayden will transition from a board director role to a newly created position as Entrepreneur in Residence effective June 30, 2025, leveraging his three decades of experience to support early-stage disruptive technology companies [2][3] - Dan Torpey has been appointed Chair of the Audit Committee effective February 13, 2025, bringing 24 years of experience as an Assurance Partner at Ernst & Young LLP, enhancing MDB's governance and operational rigor [3] Company Strategy - These leadership transitions reflect MDB's commitment to building a world-class leadership team to support its strategy of launching and scaling transformational technology ventures [4] - MDB Capital Holdings focuses on launching "Big Ideas" into valuable public companies through community-driven financings of pre-revenue, early-stage disruptive technology companies, primarily via early public offerings on NASDAQ [5]

Core Insights - ThreeD Capital Inc. reported its unaudited financial results for the three and nine months ended March 31, 2025, highlighting a focus on opportunistic investments in junior resources and disruptive technologies sectors [1][6] - The company experienced a decline in net asset value per share, dropping to $0.53 from $0.86 as of June 30, 2024 [2] Financial Highlights - As of March 31, 2025, the company had cash, investments, and digital assets totaling $37.4 million [1] - For the three months ended March 31, 2025, net investment and digital assets losses were reported at $(5,463,310), compared to gains of $4,486,530 in the same period of 2024 [2] - Operating, general, and administrative expenses for the nine months ended March 31, 2025, were $(2,812,064), an increase from $(2,581,273) in the previous year [2] - Total comprehensive loss for the period was $(5,463,838) for the three months ended March 31, 2025, compared to a gain of $3,708,589 in the same period of 2024 [2] Consolidated Financial Position - Total assets as of March 31, 2025, were $41,016,482, down from $56,174,715 as of June 30, 2024 [3] - Total liabilities decreased significantly to $633,307 from $11,455,313 [3] - The company reported a deficit of $(116,507,660) as of March 31, 2025, compared to $(107,729,192) as of June 30, 2024 [3] Management Commentary - The Chairman and CEO noted that despite the losses, the company's portfolio remains fundamentally strong, with key investments in micropayments, artificial intelligence, and digital assets achieving significant milestones [3]

IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- via IBN -- ECGI Holdings Inc. (OTC: ECGI), a diversified holding company focused on viticulture, equestrian markets, and emerging innovation, today announced the launch of Uplist Ventures (uplist.vc), a new initiative to identify, support, and scale overlooked startups with the potential to enter public markets. Uplist Ventures will invest in pre-seed through Series B companies, with a preferred focus on those at the Series A and B stages. The firm is targeti ...

Company Overview - Nvidia is set to report earnings, with analysts previously focused on how much it would surpass estimates, but the current sentiment is more cautious due to external factors [3][4] - The company's stock has only increased by 0.9% in 2025, underperforming the Nasdaq 100 index, which has risen nearly 2% [4] Market Concerns - Nvidia's significant exposure to the Chinese market, where it holds approximately 50% market share, raises concerns about the impact of tariffs and trade wars [5] - Despite the uncertainty surrounding tariffs, Nvidia's stock has rebounded 44% from recent lows following a previous downturn [5] Analyst Sentiment - Wall Street analysts express mixed feelings about Nvidia's upcoming guidance, with some expecting a "messy" second-quarter outlook and potential revenue misses, yet maintaining a generally positive long-term view on the stock [6] - Historical resilience of Nvidia in the face of challenges, such as competition and market demand fluctuations, suggests that the company may navigate current tariff concerns effectively [7] Broader Market Insights - Goldman Sachs believes that tariff-induced inflation may be temporary, suggesting that companies are adjusting prices but that the inflation impact will not be long-lasting [8] - BlackRock's bond chief highlights investment opportunities in the bond market amid recent volatility, favoring short-duration Treasurys as a strategic bet [9]

Core Viewpoint - KKR Fund has successfully raised $1 billion, establishing the largest AI-focused fund in EU history and the largest venture capital fund in Europe [2][4]. Fund Overview - The KKR Innovation Fund III has a management scale of $1 billion and aims to drive deep applications of AI in key industries such as digital healthcare, fintech, consumer, and mobility & energy [2][4]. - The fund will invest in high-growth companies across major regions including China, Southeast Asia, Europe, and North America [2]. Investment Strategy - KKR Fund focuses on the deep application of AI in specific industries rather than just investing in AI infrastructure or models [5][6]. - The fund's investment size ranges from $5 million to $80 million, allowing for leading and co-leading investments as well as follow-on funding [6]. Portfolio and Partnerships - The fund has already invested in 15 high-growth companies, including notable names like "Xinghai Tu" and "Aochuang Guangnian" [7]. - KKR Fund has established a global ecosystem by collaborating with nearly 30 Fortune 500 companies, enhancing its ability to connect startups with industry resources [7][9]. Global Perspective - KKR Fund's founder, Cai Mingpo, emphasizes the importance of helping companies navigate cross-border and international cooperation [9]. - The fund has a unique global investment platform and industry ecosystem, managing over €7 billion [9]. Market Sentiment - There is a growing interest from global investors, particularly from Europe, in investing in Chinese technology companies, reflecting a shift in attitude towards Chinese assets [13][14]. - Major investment firms like Bridgewater and Goldman Sachs have recently expressed bullish sentiments towards Chinese assets, indicating a potential revaluation of these assets [14].

目前网站就一个页面，几乎找不到详细介绍，显示是一家长期控股公司，与美国服务业领先的管理团队和 创始人合作应用前沿技术。 随着 AI 大模型能力越来越成熟，VC 们也越来越不满足于传统的投资，开始了各种新的玩法。 上个月，Benchmark 合伙人 Sarah 宣布将自己的角色从 GP 转向 Ventures Partner，希望通过 Vibe Coding 和写作的方式更深入研究 AI 后《 Benchmark 合伙人 Sarah 退出 GP，亲自上手 Vibe Coding 全力 押注 AI 》。 现在，越来越多的 VC 纷纷下场直接做孵化或者收购，自己上手利用 AI 以及资源整合能力来自动化改造传 统行业，也就是通过收购多个同类企业，利用 AI 对被收购企业进行升级改造、提升运营效率和客户体验、 整合资源实现规模效应和协同效应，这种策略被称为 AI 驱动的 Roll-up（合并整合）策略 。 具体做法包括： 其目标往往是那些类似呼叫中心，比方说我之前介绍过的《 创立 15 个月 ARR 超 9000 万美金，又一华人 参与的 AI 客服增长有点猛 》、会计师事务所等人力密集型传统企业。 主要投资于早期阶段 ...

Core Viewpoint - The article discusses the successful fundraising of a new fund, "He Guang No. 1," by Jing Shui Hu Venture Capital, which is a FOF (Fund of Funds) designed based on the needs and risk preferences of financial investors, marking a shift in their fundraising strategy [2][3]. Fundraising and Investor Trust - "He Guang No. 1" achieved a high re-investment rate and fundraising efficiency, primarily attracting high-net-worth entrepreneurs and financial investors who have previously engaged with Jing Shui Hu's funds [3]. - The fund operates as a "blind pool" without specific reserve projects, reflecting a strong trust in the management team from investors [3][4]. - The fund's duration is set at ten years, providing the investment team with greater freedom to explore early-stage investment opportunities [3][4]. Investment Strategy and Focus - Jing Shui Hu Venture Capital specializes in hard technology investments, including AI, smart energy, and data algorithms, and has successfully exited several projects through various methods [4][5]. - The fund will adopt a "PSD" strategy, focusing on growth-stage VC funds and direct investment opportunities in AI+, industrial technology, new energy, and materials [5]. Management Expertise - The management team's expertise in identifying and evaluating hard technology projects is crucial for the fund's success, as the commercialization of technology often requires long-term capital support [5]. - The FOF structure allows for a diversified portfolio, which can mitigate non-systematic risks associated with individual assets or funds [4][5].

Financial Data and Key Metrics Changes - The company reported a modest increase in its shareholder base, onboarding several new accounts interested in the HeartBeam offering [30] - Net current assets decreased by approximately $2.3 million, with less than $2 million in cash utilized during the quarter [36][37] - The enterprise value calculation indicates that the company was trading at a significant discount to its enterprise value at year-end, which has slightly decreased due to volatility in HeartBeam and Exozymes [34][35] Business Line Data and Key Metrics Changes - The company is pivoting towards companies that are closer to product revenue and value creation, indicating a shift in focus from traditional deep tech ideas [19][50] - The company has three new Letters of Intent (LOIs) with a biotech firm, a profitable beverage company, and a healthcare software company, all of which are expected to perform well in the public markets [20][21][23] Market Data and Key Metrics Changes - The venture market is experiencing a significant backlog of companies that could potentially go public, with many venture firms seeking to exit investments due to a lack of new fund formations [12][15] - The current environment is seen as favorable for small IPOs, with a growing number of companies that could be well-valued in public markets [18][51] Company Strategy and Development Direction - The company aims to curate public venture capital as a preferred alternative to traditional venture capital, focusing on transforming big ideas into valuable public companies [5][6] - The management is excited about the potential for IPOs, believing that the current market dynamics will allow for better valuations and opportunities for public investors [15][16] - The company is expanding its investor community, focusing on capital allocators rather than just deal buyers, to enhance its deal flow [50][45] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenging operating environment but remains optimistic about the potential for future growth and the ability to bring new companies public [24][51] - The management believes that the current market conditions will lead to a resurgence in small IPOs, reversing long-term downtrends [18][51] - The company is committed to finding extraordinary businesses at the right valuations, which will represent great return opportunities for investors [20][52] Other Important Information - The company has restructured its executive compensation plan to align better with shareholder interests, converting a significant amount of stock into options [32][33] - PatentVest is seen as a critical component of the company's strategy, providing essential business development and IP strategy support to portfolio companies [69][70] Q&A Session Summary Question: Can you just talk about the one company that you have that you're financing, the 20,000,000 for the potential cure for diabetes? - The company being financed is PaulX Bio [54] Question: How does management interpret the persistent discount of the MDBH stock price relative to the IPO price? - Management attributes the discount to supply and demand dynamics, noting that market perceptions can change over time [56][59] Question: What is the future dividend policy of the company? - The dividend policy will depend on the impact of share distribution on the companies involved and the company's cash flows [60][62] Question: How does MDB make money when taking a venture public? - MDB earns equity through pre-IPO financing and charges cash fees, often receiving a blend of cash and equity [65][66] Question: Can you share how much of MDB's value is due to its share of ownership of the companies you've taken public? - The value is significantly tied to the performance of companies like Exozymes and HeartBeam, with potential for substantial impact on MDB's stock price [77][79] Question: Do you ever consider acquisition of companies instead of IPOs? - Currently, the focus is on public venture, but acquisitions could be considered if they align with the company's strategy [81] Question: How many firms do you see out there that are doing what MDB Capital is doing currently? - Management believes there are very few firms that effectively compete with MDB's unique approach to public venture capital [82][84]

Financial Data and Key Metrics Changes - The company reported a modest increase in its shareholder base, onboarding several new accounts interested in the HeartBeam offering [29] - Net current assets decreased by approximately $2.3 million, with less than $2 million in cash utilized during the quarter [35] Business Line Data and Key Metrics Changes - The company is pivoting towards companies that are closer to product revenue and value creation, indicating a shift in focus from deep tech ideas to more profitable ventures [19][48] - The company has three letters of intent (LOIs) with new companies, including a biotech firm with a pre-money valuation of $20 million, a profitable beverage company, and a healthcare software company [20][22][23] Market Data and Key Metrics Changes - The current venture market is characterized by a significant number of companies that have received funding but have not gone public, creating opportunities for the company to take these firms public [11][12] - The company noted a backlog of IPO opportunities due to changing market dynamics, with investors preferring companies that are capital light and closer to profitability [15][17] Company Strategy and Development Direction - The company aims to scale its operations by bringing three to four new investment opportunities to the public market each year, focusing on companies that can resonate in the changing marketplace [43][44] - The management emphasized the importance of valuation and the need to find extraordinary businesses at the right values to provide great return opportunities for investors [20][50] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the small IPO market, suggesting it will be robust and may reverse long-standing downtrends [17] - The management acknowledged the current challenging environment for small companies but remains confident in the company's ability to curate and take public viable businesses [24][49] Other Important Information - The company has restructured its executive compensation plan to align better with shareholder interests, converting a significant amount of stock compensation to options [31][32] - PatentVest is seen as a critical component for value creation, assisting in business development and strategy for the companies it works with [66][70] Q&A Session Summary Question: Can you talk about the company financing the $20 million for the potential cure for diabetes? - The company financing this is PaulX Bio [52] Question: How does management interpret the persistent discount of the MDBH stock price relative to the IPO price? - Management believes it is primarily a supply and demand issue, noting that market perceptions can change over time [54][56] Question: What is the future dividend policy? - The dividend policy will depend on the impact of share distribution on the companies involved and the company's cash flows [58][60] Question: How does the company make money when taking a venture public? - The company earns equity through pre-IPO financing and charges cash fees, often receiving a blend of cash and equity [62][63] Question: How much of MDB's value is due to its share of ownership of the companies taken public? - The company believes that if it had gone public at a better time, its valuation would be significantly higher [74][76] Question: Does the company consider acquisitions instead of IPOs? - Currently, the focus is on public ventures, but the company would consider acquisitions if they are accretive to its public venture strategy [79] Question: How many firms are doing what MDB Capital is doing currently? - Management believes there are very few firms left that can effectively take small companies public, highlighting the company's unique position [81][82]